Day One: Wednesday April 24, 2019
REGISTRATION & COFFEE
8:00
Introduction and Summary
8:15
Novel Antibody Constructs for Breast Cancer
8:30
Arming antibodies for the fight against cancer
Michael Fleming
Scientist II
ImmunoGen
9:00
Progressing our mechanistic understanding of anti-CTLA-4 therapy: next generation anti-CTLA-4 antibodies for cancer immunotherapy
Dhan Chand
Senior Scientist
Agenus
9:30
Sacituzumab Govitecan: Scientific rationale and clinical development in breast cancer
Martin Olivo
VP, Clinical Development
Immunomedics
10:00
CONJUGATION AND FILL fiNISH - HOW TO SECURE THE SUPPLY CHAIN OF ADCs
Giorgio Salciarini
Technical Business Development Manager
BSP Pharmaceuticals
MORNING REFRESHMENTS & SPEED NETWORKING
10:30
11:30
ZW49: Combining the Azymetric and ZymeLink platforms to expand the therapeutic window of a bispecific HER2-targeting ADC
Rupert Davies
Principal Scientist, Oncology
Zymeworks
Immunotherapy in Breast Cancer
12:00
Immunotherapy in Breast Cancer: Moving forward
Dimitrios Zardavas
Program Lead, Breast Cancer
Bristol Myers Squibb
12:30
Capturing Drug-Induced Modulation of the Tumor Microenvironment Using A Personalized Ex Vivo Histoculture Approach
Stefan Jellbauer
Technical Liaison, Biopharma Business Development
Mitra Biotech
LUNCH & NETWORKING
1:00
2:00
Imprime PGG, a novel Dectin Receptor agonist, in combination with pembrolizumab for metastatic triple negative breast cancer (mTNBC)
Jeremy Graff
President, CSO
Biothera
2:30
Development of combination immunotherapy for breast cancer
Sarah Wang
Principal Scientist, Translational R&D
TESARO
3:00
Can Cancer Immunotherapy be both Personalized and Off-the-Shelf?
William Williams
Chief Executive Officer
Briacell
AFTERNOON REFRESHMENTS & NETWORKING
3:30
4:00
Discovery of Novel Linker Payloads and Antibody Drug Conjugates for the Treatment of Cancer
Omar Ahmad
Principal Scientist, Group Leader
Pfizer
4:30
The developing treatment for triple negative breast cancer utilizing a multi-functional immunotherapeutic platform
Mahesh Narayanan
CEO
PepVax
DRINKS RECEPTION & NETWORKING
5:00
VIEW NEXT DAY
CONNECT!
Follow Our Latest News on Twitter
DOWNLOAD EVENT GUIDE
Complete the form below to download the PDF
NEO SYNTH International House, 24 Holborn Viaduct, London EC1A 2BN
contact@neo-synth.com
(+1) 617.500.5172
Your details will not be shared with a third party
Copyright © 2016 | All content produced by: neo-synth ltd.